BioCentury
ARTICLE | Company News

EMO-FARM, Valeant Pharmaceuticals International deal

May 18, 2009 7:00 AM UTC

Valeant acquired dermatology company EMO-FARM for $28 million in cash. EMO-FARM markets a number of products including naproxen analgesic and anti-inflammatory gel and Emorect anti-inflammatory, anti-...